The Department of Gene Therapy and Hepatology of the Center for Applied Medical Research (CIMA) of the University of Navarra has identified a molecule as possibly effective for improving the treatment of chronic hepatitis and liver cancer.

Medicinal plants have been used as traditional remedies for hundreds of years. Among them, S. barbata has been traditionally used in treatment of hepatitis, inflammation, osteomyelitis and gynecological diseases in China.

Varying Combinations of Antiviral Drugs May Effectively Treat Chronic Hepatitis Virus Infection in Woodchucks and Have Implications for use in Humans

Viruses dramatically increase cellular metabolism, and existing anti-obesity drugs may represent a new way to block these metabolic changes and inhibit viral infection, according to a study published today in the journal Nature Biotechnology.

Halothane is a volatile anesthetic, which was first introduced to clinical practice in 1956. In Iran, halothane is being used as the main anesthetic in more than 80% of hospitals. Unfortunately, increasing numbers of HH are being reported in Iran.

Greystone Associates Assessment Identifies a Number of Therapy Areas Where Pens are Achieving Double-Digit Growth

Scientists from the University of Granada (Spain), in collaboration with the University of León, have confirmed that stem cells from human umbilical cord blood can be an appropriate therapy for the treatment of hepatic diseases such as hepatitis, and are therefore an effective alternative to bone marrow.

Ants may be an unwelcome intruder at picnics, but they could soon be a welcome guest in your medicine cabinet. Chemists in China report identification of substances in a certain species of ants that show promise for fighting arthritis, hepatitis, and other diseases. Their study is scheduled for the April 25 issue of ACS’ Journal of Natural Products, a monthly publication.

Hepatitis viruses have a strong tropism for hepatocytes; viral antigen also has been detected in pancreas and gallbladder. Acute pancreatitis is common in Fulminant hepatic failure but rarely reported in acute viral hepatitis.

The outcome of hepatitis is either self recovery or its development into liver fibrosis or, further, liver cirrhosis. Liver fibrosis is the early pathological process of cirrhosis, which is considered a reversible, wound-healing response.

Researchers at the La Jolla Institute for Allergy & Immunology have shown that cytomegalovirus (CMV) in the salivary glands can be reduced - and in some cases eliminated - through the use of antibodies to enhance the disease-fighting power of the immune system.

The way the liver renews itself may be simpler than what scientists had been assuming. A new study, appearing in the April 13 issue of The Journal of Biological Chemistry, provides new information on the inner workings of cells from regenerating livers that could significantly affect the way physicians make livers regrow in patients with liver diseases such as cirrhosis, hepatitis, or cancer.